Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R. P. Scherer proxy battle

Executive Summary

Annual meeting, which began on Aug. 17, will reconvene on Aug. 24. At that time, the results of a shareholder vote relating to three director seats and a proposal made by Carla Scherer fink and brother John Scherer will be announced. In a 180-degree turnaround, Bessemer Securities, a New York investment company with a 6.6% interest in R. P. Scherer, has decided to vote in favor of company management, according to a recent 13D filing. Previously, Bessemer had supported Carla Fink's proposal to sell the company. The status of 9.3% of the company's voting power, which is held in trust, remains uncertain

Latest Headlines
See All
UsernamePublicRestriction

Register

PS014178

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel